Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer-Reference-Cited by-同舟云学术

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer

Published:2019 Issue:2 Volume:4 Page:e000474
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Fountzilas Elena^ORCID,Kotoula Vassiliki,Pentheroudakis George,Manousou Kyriaki,Polychronidou Genovefa,Vrettou Eleni,Poulios Christos,Papadopoulou Eirini,Raptou Georgia,Pectasides Eirini,Karayannopoulou Georgia,Chrisafi Sofia,Papakostas Pavlos,Makatsoris Thomas,Varthalitis Ioannis,Psyrri Amanda,Samantas Epaminontas,Bobos Mattheos,Christodoulou Christos,Papadimitriou Christos,Nasioulas George,Pectasides Dimitrios,Fountzilas George

Funder

Hellenic Cooperative Oncology Group

AstraZeneca

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference79 articles.

1. Milestones of Lynch syndrome: 1895-2015;Lynch;Nat Rev Cancer,2015

2. Comprehensive molecular characterization of human colon and rectal cancer;Cancer Genome Atlas Network;Nature,2012

3. Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer;Fountzilas;Oncotarget,2018

4. Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data;Middha;JCO Precis Oncol,2017

5. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS;Kautto;Oncotarget,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Implications of Mismatch Repair Status in Endometrioid Endometrial Cancer in Duhok City;Cureus;2024-03-25

2. Mismatch repair proteins evaluation in endometrial carcinoma: clinicopathological features and prognostic implications;European Journal of Gynaecological Oncology;2024

3. Association of mismatch repair deficiency in endometrial cancer with 18F-FDG PET/CT and clinicopathological features and their prognostic value;Annals of Nuclear Medicine;2023-09-24

4. Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer;Cancers;2023-07-19

5. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer;New England Journal of Medicine;2023-06-08